Sort   by:  
 Page size 
UnknownLenalidomide and rituximab for the initial treatment of patients with chronic lymphocytic leukemia: a multicenter clinical-translational study from the chronic lymphocytic leukemia research consortium.
Not available
S-EPMC4067945 | biostudies-literature
UnknownPhase I Study of Single-Agent AZD1775 (MK-1775), a Wee1 Kinase Inhibitor, in Patients With Refractory Solid Tumors.
Not available
S-EPMC4606059 | biostudies-literature
UnknownT Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma.
Not available
S-EPMC6067798 | biostudies-literature
UnknownAllogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease.
Not available
S-EPMC4872017 | biostudies-literature
UnknownWorldwide research performance on telemedicine for newborns and neonatal intensive care units: A bibliometric and visualization study.
Not available
S-EPMC12035156 | biostudies-literature
UnknownEffects of a brief multimedia psychoeducational intervention on the attitudes and interest of patients with cancer regarding clinical trial participation: a multicenter randomized controlled trial.
Not available
S-EPMC4577714 | biostudies-literature
TranscriptomicsTranscription profiling of human lung fibroblasts exposed to vanadium pentoxide to identifiy genes associated with vanadium pentoxide-induced bronchitis
Exposure to vanadium pentoxide (V2O5) is a cause of occupational bronchitis. We evaluated gene expression profiles in cultured human lung fibroblasts exposed to V2O5 in vitro in order to identify candidate genes that could play a role in airway remodeling associated with V2O5-induced bronchitis. Gen...
ORGANISM(S): Homo sapiens 
2008-11-22 | E-GEOD-5339 | biostudies-arrayexpress
TranscriptomicsTranscription profiling of human bronchial epithelial cells treated with interferon gamma and/or dexamethasone
RNA from cultured human bronchial epithelial cells treated for 8 hours or for 24 hours with medium alone, interferon gamma, dexamethasone or both interferon gamma and dexamethasone.
ORGANISM(S): Homo sapiens 
2007-08-25 | E-GEOD-1815 | biostudies-arrayexpress
UnknownBRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma.
Not available
S-EPMC4356711 | biostudies-literature
UnknownRacial And Ethnic Disparities In Buprenorphine Receipt Among Medicare Beneficiaries, 2015-19.
Not available
S-EPMC10910625 | biostudies-literature
Sort   by:  
 Page size